269 related articles for article (PubMed ID: 35203677)
1. The Autoantibodies against Tumor-Associated Antigens as Potential Blood-Based Biomarkers in Thyroid Neoplasia: Rationales, Opportunities and Challenges.
Belousov PV
Biomedicines; 2022 Feb; 10(2):. PubMed ID: 35203677
[TBL] [Abstract][Full Text] [Related]
2. Multi-dimensional immunoproteomics coupled with in vitro recapitulation of oncogenic NRAS
Belousov PV; Afanasyeva MA; Gubernatorova EO; Bogolyubova AV; Uvarova AN; Putlyaeva LV; Ramanauskaite EM; Kopylov AT; Demin DE; Tatosyan KA; Ustiugova AS; Prokofjeva MM; Lanshchakov KV; Vanushko VE; Zaretsky AR; Severskaia NV; Dvinskikh NY; Abrosimov AY; Kuprash DV; Schwartz AM
Cancer Lett; 2019 Dec; 467():96-106. PubMed ID: 31326556
[TBL] [Abstract][Full Text] [Related]
3. A new method combining sequential immunoaffinity depletion and differential in gel electrophoresis to identify autoantibodies as cancer biomarkers.
Grandjean M; Dieu M; Raes M; Feron O
J Immunol Methods; 2013 Oct; 396(1-2):23-32. PubMed ID: 23916966
[TBL] [Abstract][Full Text] [Related]
4. Serum Immunoproteomics Combined With Pathological Reassessment of Surgical Specimens Identifies TCP-1ζ Autoantibody as a Potential Biomarker in Thyroid Neoplasia.
Belousov PV; Bogolyubova AV; Kim YS; Abrosimov AY; Kopylov AT; Tvardovskiy AA; Lanshchakov KV; Sazykin AY; Dvinskikh NY; Bobrovskaya YI; Selivanova LS; Shilov ES; Schwartz AM; Shebzukhov YV; Severskaia NV; Vanushko VE; Moshkovskii SA; Nedospasov SA; Kuprash DV
J Clin Endocrinol Metab; 2015 Sep; 100(9):E1206-15. PubMed ID: 26196948
[TBL] [Abstract][Full Text] [Related]
5. Using immunoproteomics to identify tumor-associated antigens (TAAs) as biomarkers in cancer immunodiagnosis.
Zhu Q; Liu M; Dai L; Ying X; Ye H; Zhou Y; Han S; Zhang JY
Autoimmun Rev; 2013 Oct; 12(12):1123-8. PubMed ID: 23806562
[TBL] [Abstract][Full Text] [Related]
6. Systematic review: Tumor-associated antigen autoantibodies and ovarian cancer early detection.
Fortner RT; Damms-Machado A; Kaaks R
Gynecol Oncol; 2017 Nov; 147(2):465-480. PubMed ID: 28800944
[TBL] [Abstract][Full Text] [Related]
7. Autoantibody repertoire profiling in tissue and blood identifies colorectal cancer-specific biomarkers.
Zhang PF; Wu Z; Zhou T; Yang DW; Mu QK; Zhang WB; Yu L; Zhang SD; Hu YZ; Mu J; Jia WH
Cancer Sci; 2024 Jan; 115(1):83-93. PubMed ID: 37985391
[TBL] [Abstract][Full Text] [Related]
8. Survey of autoantibody responses against tumor-associated antigens in thyroid cancer.
Abols A; Ducena K; Zayakin P; Silina K; Kalnina Z; Sadovska L; Tars J; Vilmanis J; Narbuts Z; Eglitis J; Pirags V; Line A
Cancer Biomark; 2014; 14(5):361-9. PubMed ID: 25171478
[TBL] [Abstract][Full Text] [Related]
9. Tumor associated antigens or anti-TAA autoantibodies as biomarkers in the diagnosis of ovarian cancer: a systematic review with meta-analysis.
Shi JX; Qin JJ; Ye H; Wang P; Wang KJ; Zhang JY
Expert Rev Mol Diagn; 2015 Jun; 15(6):829-52. PubMed ID: 25959246
[TBL] [Abstract][Full Text] [Related]
10. Clinical value of tumor-associated antigens and autoantibody panel combination detection in the early diagnostic of lung cancer.
Ouyang R; Wu S; Zhang B; Wang T; Yin B; Huang J; Wei W; Huang M; Zhang M; Wang Y; Wang F; Hou H
Cancer Biomark; 2021; 32(3):401-409. PubMed ID: 34151844
[TBL] [Abstract][Full Text] [Related]
11. Autoantibodies to tumor-associated antigens in breast carcinoma.
Piura E; Piura B
J Oncol; 2010; 2010():264926. PubMed ID: 21113302
[TBL] [Abstract][Full Text] [Related]
12. Nonthyroid autoantibodies in obese strain (OS) chickens.
Aichinger G; Kofler H; Diaz-Merida O; Wick G
Clin Immunol Immunopathol; 1984 Jul; 32(1):57-69. PubMed ID: 6428787
[TBL] [Abstract][Full Text] [Related]
13. Autoantibodies to tailor-made panels of tumor-associated antigens in breast carcinoma.
Piura E; Piura B
J Oncol; 2011; 2011():982425. PubMed ID: 21423545
[TBL] [Abstract][Full Text] [Related]
14. The impact of concurrent Hashimoto thyroiditis on thyroid nodule cytopathology assessed by ultrasound-guided fine-needle aspiration cytology.
Hu F; Yan Z; Ma B; Jiang Y; Huang H
Postgrad Med; 2020 Aug; 132(6):506-511. PubMed ID: 32133896
[No Abstract] [Full Text] [Related]
15. High-throughput and multi-phases identification of autoantibodies in diagnosing early-stage breast cancer and subtypes.
Luo R; Zheng C; Song W; Tan Q; Shi Y; Han X
Cancer Sci; 2022 Feb; 113(2):770-783. PubMed ID: 34843149
[TBL] [Abstract][Full Text] [Related]
16. Human recombinant anti-thyroperoxidase autoantibodies: in vitro cytotoxic activity on papillary thyroid cancer expressing TPO.
Rebuffat SA; Morin M; Nguyen B; Castex F; Robert B; Péraldi-Roux S
Br J Cancer; 2010 Mar; 102(5):852-61. PubMed ID: 20145622
[TBL] [Abstract][Full Text] [Related]
17. Autoantibodies against TYMS and PDLIM1 proteins detected as circulatory signatures in Indian breast cancer patients.
Gupta P; Suman S; Mishra M; Mishra S; Srivastava N; Kumar V; Singh PK; Shukla Y
Proteomics Clin Appl; 2016 May; 10(5):564-73. PubMed ID: 27068564
[TBL] [Abstract][Full Text] [Related]
18. Autoantibodies against heat shock proteins as biomarkers for the diagnosis and prognosis of cancer.
Shi L; Chevolot Y; Souteyrand E; Laurenceau E
Cancer Biomark; 2017; 18(2):105-116. PubMed ID: 27983529
[TBL] [Abstract][Full Text] [Related]
19. Autoantibodies to tumor-associated antigens as biomarkers in cancer immunodiagnosis.
Liu W; Peng B; Lu Y; Xu W; Qian W; Zhang JY
Autoimmun Rev; 2011 Apr; 10(6):331-5. PubMed ID: 21167321
[TBL] [Abstract][Full Text] [Related]
20. Thyroid fine-needle aspiration cytology: performance data of neoplastic and malignant cases as identified from 1558 responses in the ASCP Non-GYN Assessment program thyroid fine-needle performance data.
Eilers SG; LaPolice P; Mukunyadzi P; Kapur U; Wendel Spiczka A; Shah A; Saleh H; Adeniran A; Nunez A; Balachandran I; Clark JJ; Lemon L
Cancer Cytopathol; 2014 Oct; 122(10):745-50. PubMed ID: 24913410
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
